KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,585,000 | -20.0% | 146,855 | -0.3% | 0.01% | -20.0% |
| Q3 2016 | $8,229,000 | +12.6% | 147,320 | +0.7% | 0.01% | +11.1% |
| Q2 2016 | $7,311,000 | +41.9% | 146,226 | +30.3% | 0.01% | +28.6% |
| Q1 2016 | $5,153,000 | -13.6% | 112,234 | +16.0% | 0.01% | -12.5% |
| Q4 2015 | $5,961,000 | +11.4% | 96,738 | +0.6% | 0.01% | +14.3% |
| Q3 2015 | $5,352,000 | -10.1% | 96,118 | -1.6% | 0.01% | 0.0% |
| Q2 2015 | $5,953,000 | +291.9% | 97,633 | +270.6% | 0.01% | +250.0% |
| Q1 2015 | $1,519,000 | -11.0% | 26,343 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $1,706,000 | +156.2% | 29,574 | +26.6% | 0.00% | +100.0% |
| Q3 2014 | $666,000 | – | 23,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |